Biotech News
iSpecimen Reports First Quarter 2023 Results
Quarterly Revenue Increased 17% Year-Over-Year
LEXINGTON, Mass., May 04, 2023 (GLOBE NEWSWIRE) -- iSpecimen...
Related news
iSpecimen
iSpecimen is a healthcare data and biospecimen marketplace company that connects researchers with human biospecimens and related services. Its role is to support research and translational work rather than develop therapies.
Recent company news
ISPCiSpecimen2025-01-16 16:01 EST
iSpecimen Secures Suppliers for COVID-style hMPV Outbreak
ISPCiSpecimen2024-12-20 08:30 EST
iSpecimen Will Serve as a Preferred Provider of Cancer Biospecimens
ISPCiSpecimen2024-12-13 07:30 EST
iSpecimen Reports Positive Results on Next Day Quote Program for Researchers and Providers
ISPCiSpecimen2024-12-12 17:11 EST
iSpecimen Appoints Robert Lim as CEO and Director
ISPCiSpecimen2024-11-08 07:30 EST
iSpecimen Named Top Competitor in $4.4 Billion USD Market
Stock data
- Close
- 1.69 USD
- Market cap
- 4.41M USD
- Exchange
- NASDAQ
- Sector
- Biopharma
- Location
- United States